NANO Past Earnings Performance
Past criteria checks 0/6
NANO's earnings have been declining at an average annual rate of -34.8%, while the Chemicals industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 8% per year.
Key information
-34.8%
Earnings growth rate
-33.1%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 8.0% |
| Return on equity | -22.8% |
| Net Margin | -1.9% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How NANO makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 89,191 | -1,667 | 7,904 | 435 |
| 31 Dec 23 | 88,076 | -4,725 | 7,814 | 421 |
| 30 Sep 23 | 80,272 | -10,587 | 9,218 | 157 |
| 30 Jun 23 | 79,302 | -11,567 | 9,408 | 157 |
| 31 Mar 23 | 73,450 | -14,010 | 9,587 | 292 |
| 31 Dec 22 | 66,805 | -11,725 | 8,746 | 347 |
| 30 Sep 22 | 71,926 | -5,681 | 7,284 | 463 |
| 30 Jun 22 | 63,931 | -4,669 | 6,508 | 463 |
| 31 Mar 22 | 52,577 | -14,387 | 6,009 | 328 |
| 31 Dec 21 | 51,270 | -14,838 | 6,530 | 341 |
| 30 Sep 21 | 50,675 | -12,547 | 7,130 | 397 |
| 30 Jun 21 | 48,870 | -13,085 | 7,033 | 397 |
| 31 Mar 21 | 48,049 | -2,779 | 7,079 | 377 |
| 31 Dec 20 | 47,375 | -1,883 | 6,173 | 391 |
| 30 Sep 20 | 27,007 | 3,709 | 4,785 | 332 |
| 30 Jun 20 | 30,251 | 3,482 | 5,124 | 332 |
| 31 Mar 20 | 44,342 | 3,486 | 5,362 | 242 |
| 31 Dec 19 | 53,080 | 2,614 | 5,609 | 198 |
| 30 Sep 19 | 77,379 | -1,898 | 7,560 | 285 |
| 30 Jun 19 | 78,845 | -1,719 | 7,185 | 285 |
| 31 Mar 19 | 82,731 | -1,102 | 7,471 | 305 |
| 31 Dec 18 | 81,943 | -742 | 8,161 | 352 |
| 30 Sep 18 | 72,617 | 1,479 | 7,930 | 243 |
| 30 Jun 18 | 73,155 | 1,686 | 7,785 | 243 |
| 31 Mar 18 | 71,839 | 1,458 | 7,671 | 315 |
| 31 Dec 17 | 73,089 | -45 | 7,848 | 348 |
| 30 Sep 17 | 71,956 | -14,126 | 9,083 | 566 |
| 30 Jun 17 | 65,731 | -15,021 | 10,062 | 566 |
| 31 Mar 17 | 53,601 | -22,696 | 10,944 | 460 |
| 31 Dec 16 | 48,175 | -22,485 | 10,922 | 482 |
| 30 Sep 16 | 50,124 | -12,505 | 10,545 | 424 |
| 30 Jun 16 | 45,382 | -12,121 | 10,066 | 424 |
| 31 Mar 16 | 38,481 | -9,711 | 8,478 | 360 |
| 31 Dec 15 | 29,902 | -8,719 | 7,513 | 327 |
| 30 Sep 15 | 21,924 | -6,037 | 5,432 | 276 |
| 30 Jun 15 | 20,697 | -5,697 | 4,087 | 276 |
| 31 Mar 15 | 28,549 | -679 | 4,064 | 473 |
| 31 Dec 14 | 38,272 | 53 | 4,497 | 359 |
| 30 Sep 14 | 52,014 | 1,225 | 5,076 | 243 |
| 30 Jun 14 | 65,063 | 2,162 | 5,911 | 261 |
| 31 Mar 14 | 63,915 | 1,957 | 5,692 | 244 |
| 31 Dec 13 | 62,767 | 1,752 | 5,353 | 268 |
Quality Earnings: A187790 is currently unprofitable.
Growing Profit Margin: A187790 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A187790 is unprofitable, and losses have increased over the past 5 years at a rate of 34.8% per year.
Accelerating Growth: Unable to compare A187790's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A187790 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.5%).
Return on Equity
High ROE: A187790 has a negative Return on Equity (-22.76%), as it is currently unprofitable.